Switching from a metered dose inhaler to a dry powder version for maintenance therapy more than halves the carbon footprint of people with asthma, and without any worsening of their condition ...

Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in one healthcare system formulary led to increased healthcare utilization ...

Journal reference: Woodcock, A., et al. (2022) Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis.

Dr. Miguel Divo shows his patient, Dr. Joel Rubinstein, a dry powder inhaler. It has a much lower carbon footprint than a traditional inhaler while being equally effective for many patients with ...

Patients who switched to dry powder inhalers have largely stuck with them, Green says, and appreciate using a device that is less likely to exacerbate the environmental conditions that inflame asthma.

Session ID: 2025-08-01:4c7a3985c3a55831994250c Player Element ID: vjs_video_3 ...

The other single-inhaler on the market for COPD triple therapy, fluticasone-umeclidinium-vilanterol, is a dry-powder inhaler that does not contain hydrofluoroalkane-134a.

Glaxo Smith Kline (GSK) announced in May that Flovent HFA, a metered-dose inhaler, as well as Flovent Diskus, a dry powder inhaler, would be discontinued as of Dec. 31, 2023. Experts weigh in.

The 2019 Dry Powder Inhaler Devices pipeline is characterized by presence of 19 companies, actively assessing their devices. In particular, 10 companies are assessing their products in clinical phase.

Source Reference: Rabin AS, et al "Budesonide-formoterol metered-dose inhaler vs fluticasone-salmeterol dry-powder inhaler" JAMA Intern Med 2025; DOI: 10.1001/jamainternmed.2025.2299.